Back to search

Article

A Case of Excessive, Opportunistic Price Increase of a Generic Oncology Drug

2025-07-06

Abstract excerpt

<h4>Background: </h4> Off-patent, generic drugs are expected to be widely accessible owing competitive pricing and minimal R&D costs. Sudden, excessive, unexplainable, and sustained price increases detrimentally impact the health and welfare of patients and their families. Overlooking such cases encourages repeat behavior that may be legislatively challenging to overcome, thereby impeding the principle of democrat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0b77acae-2045-588d-810a-b0bcb87b124a
DOI
10.1101/2025.07.05.25330918
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Case of Excessive, Opportunistic Price Increase of a Generic Oncology DrugDOI 10.1101/2025.07.05.25330918
Navigating the Pharmaceutical Patent Landscape: Impact of Patent Cliffs on Innovation and AccessibilitySemantic proximity
When Do Drug Shortages Raise Acquisition Costs? Average Duration Effects and Heterogeneous Price Pass-ThroughSemantic proximity
Availability, Prices and Affordability of Nationally Negotiated Antidiabetic Drugs in China: A National SurveySemantic proximity
How Low Could Semaglutide Prices Fall? An Analysis of Production Cost and Implications for Global Access Ahead of Patent ExpirySemantic proximity
A Study on the Heterogeneous Effects of China’s Volume- Based Procurement on Gastrointestinal and Metabolic MedicationsSemantic proximity
Methodological Challenges in Dutch HTA of Non-Oncological Orphan Drugs: A Retrospective Analysis and Price Comparison Using different Pricing ModelsSemantic proximity
Prescription volume and costs of over-the-counter–like drugs in Japan by patient and healthcare facility characteristics: A nationwide descriptive studySemantic proximity
The clinician impact and financial cost to the NHS of litigation over pregabalin: a cohort study in English primary careSemantic proximity
Ethical and human subject burdens of trials conducted to evaluate biosimilarsSemantic proximity
Are quality medicines affordable? Evidence from a large survey of medicine price and quality in IndonesiaSemantic proximity
Shining a light in the black box of orphan drug pricingSemantic proximity
What Ails Drug Supply Chains? A Model for Diagnosis and Suggestions for a CureSemantic proximity
Select a neighboring publication to make it the new centre.